FR2265403A1 - Growth-hormone inhibiting tetradecapeptide solns - for injection, with prolonged action by forming a complex with e.g. heavy metal salts - Google Patents
Growth-hormone inhibiting tetradecapeptide solns - for injection, with prolonged action by forming a complex with e.g. heavy metal saltsInfo
- Publication number
- FR2265403A1 FR2265403A1 FR7510079A FR7510079A FR2265403A1 FR 2265403 A1 FR2265403 A1 FR 2265403A1 FR 7510079 A FR7510079 A FR 7510079A FR 7510079 A FR7510079 A FR 7510079A FR 2265403 A1 FR2265403 A1 FR 2265403A1
- Authority
- FR
- France
- Prior art keywords
- complex
- injection
- phe
- growth
- tetradecapeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Aq. compsns. for injection, having a prolonged duration of action, contain the peptide of formula (I) H.Ala.Gly.Cys.Lys.Asn.Phe.Phe.Trp.Lys.Thr.Phe.Thr.Ser.Cys.OH (I) in the form of a complex produced by adding an inorg. salt (esp. halides, phosphates, pyro-phosphates or polyphosphates) of Ca, Co, Mg, Mn, Al or Zn; and/or a polymer such as polyoxygelatine, polyvinyl-pyrrolidone, carboxymethyl-cellulose or sulphnoc acid or phosphoric acid esters of alginic acid, dextran, polyphenols or polyalcohols. Esp. pref. is the addition of polyphloretin phosphate to (I). (I) inhibits are secretion of growth hormone but the action is short-lived when (I) is used as such. As a complex its activity persists for many hours. The compsns. are used for treating diabetes mellitus, acromegalia, and angiopathia and as diagnostic reagents.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH457474 | 1974-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2265403A1 true FR2265403A1 (en) | 1975-10-24 |
Family
ID=4278626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7510079A Withdrawn FR2265403A1 (en) | 1974-04-02 | 1975-04-01 | Growth-hormone inhibiting tetradecapeptide solns - for injection, with prolonged action by forming a complex with e.g. heavy metal salts |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE2512943A1 (en) |
FR (1) | FR2265403A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0187361A2 (en) * | 1985-01-05 | 1986-07-16 | Hoechst Aktiengesellschaft | Sustained-release compositions, process for preparing them and suitable compositions for medical or veterinary use |
EP0193917A2 (en) * | 1985-03-06 | 1986-09-10 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
US5456922A (en) * | 1985-03-06 | 1995-10-10 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
-
1975
- 1975-03-24 DE DE19752512943 patent/DE2512943A1/en active Pending
- 1975-04-01 FR FR7510079A patent/FR2265403A1/en not_active Withdrawn
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0187361A2 (en) * | 1985-01-05 | 1986-07-16 | Hoechst Aktiengesellschaft | Sustained-release compositions, process for preparing them and suitable compositions for medical or veterinary use |
EP0187361A3 (en) * | 1985-01-05 | 1987-10-21 | Hoechst Aktiengesellschaft | Sustained-release compositions, process for preparing them and suitable compositions for medical or veterinary use |
EP0193917A2 (en) * | 1985-03-06 | 1986-09-10 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
EP0193917A3 (en) * | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
US5456922A (en) * | 1985-03-06 | 1995-10-10 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
Also Published As
Publication number | Publication date |
---|---|
DE2512943A1 (en) | 1975-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koulourides et al. | Rehardening of softened enamel surfaces of human teeth by solutions of calcium phosphates | |
Meyer et al. | Effect of stannous and fluoride ions on the rate of crystal growth of hydroxyapatite | |
EP0334060A3 (en) | Denture cleansing tablet | |
FR2265403A1 (en) | Growth-hormone inhibiting tetradecapeptide solns - for injection, with prolonged action by forming a complex with e.g. heavy metal salts | |
Moschler et al. | Lime and soil acidity effects on alfalfa growth in a red‐yellow podzolic soil | |
Vatn et al. | The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man | |
GB1330596A (en) | Prevention or inhibition of scale deposition from aqueous systems | |
EP0171477A3 (en) | Amino acid-containing therapeutic compounds | |
ES8404214A1 (en) | A method of manufacturing a foundry mould mix containing binder components and mould binder components therefor. | |
Cooper | Some chemical considerations on the distribution of iron in the sea | |
ES455829A1 (en) | Method of treating phosphate-containing material to reduce problem with clay swelling | |
Lawton et al. | The effect of liming on the utilization of soil and fertilizer phosphorus by several crops grown on acid organic soils | |
GB1271388A (en) | Method of making phosphors | |
Merc et al. | Potentiometric study of vitamin D3 complexes with manganese (II), iron (II), iron (III) and zinc (II) in water—ethanol medium | |
US2982690A (en) | Injectable veterinary iron compositions | |
Nancollas et al. | The effect of stannous fluoride, sodium fluoride and stannous chloride on the crystallization of dicalcium phosphate dihydrate at constant pH | |
GB1522159A (en) | Process for the stabilisation of calciumhydrogenphosphate-dihydrate against hydrolysis | |
IE41504L (en) | Cold working of stainless steels using carbon fluoride. | |
AU8274175A (en) | Chelates of 1,2-diaminocyclohexane tetrakis %methylene phosphonic acid< useful for supplying nutrient metals to plants growing in calcareous soil | |
DE956098C (en) | Process for the preparation of zinc-rich insulin complex compounds | |
GB1522158A (en) | Process for the stabilisation of calcium hydrogenphosphate-dihydrate against hydrolysis | |
DE742580C (en) | Process for the transfer of phosphate and phosphoric acid-containing waste gypsum slurries into fertilizers | |
FR2058980A5 (en) | Zinc magnesium silicogermanate phosphors | |
IL33381A (en) | Process for removing manganese from phosphoric acids or acid alkali metal phosphate solutions | |
US4210636A (en) | Antisecretory polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Withdrawal of published application |